08.28.25 -- Explore Cell & Gene Therapy CDMOs With Available Capacity For Tailored Solutions

PCI is positioned to meet the future of sterile pharmaceutical development and manufacturing with technology and solutions for high-value biologics, complex formulations, and lyophilized drug products.

Gain an overview of a new state-of-the-art Groninger filling line’s capabilities, production scale-up timelines, and how this new infrastructure supports product flexibility and long-term growth for partners.

Novartis Contract Manufacturing introduces their fill and finish solutions and capacity. Explore an overview of the aseptic network of Novartis and the capabilities of each site.

INCOG's balanced framework addresses the unique challenges of sterile manufacturing by integrating risk-based decision making with systematic capacity planning.

Excellos leverages its extensive starting material expertise as a key differentiator. Deep understanding of partner-sourced raw materials, quality control, and supply chain management creates significant value.

Andelyn Biosciences has used its Curator™ adherent platform to manufacture more than 450 Phase 1 and 2 clinical batches, spanning over 17 years and covering a variety of serotypes and indications.

As a leading CDMO in AAV manufacturing, Viralgen facilitates rapid transition to cGMP with a proven platform and an impeccable 100% IND success rate. Discover how Viralgen drives industry progress.

With a robust track record of more than 7,500 GMP batches and proven platforms for multiple modalities, Minaris delivers speed, scalability, and reliability to help therapeutic developers bring cures to patients faster.

ReciBioPharm’s specialized CDMO capabilities include development and manufacture for new biological modalities. Choose a CDMO with complete end-to-end services and in-house analytical capabilities.

Alcami’s laboratory services can support many drug substance or drug product modalities, all product phases, and specialty services, including in-house microbiology, raw materials, and analytical development.

Explore real examples of how KBI Biopharma has supported partners through transparency that empowers, integration that simplifies, methods that de-risk, and experience that accelerates.

Pedro Morales, Director, Scientific Advisor of Biologics Analytical Services, explores how Catalent delivers tailored solutions through deep expertise and advanced capabilities.